Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively. It is less potent to FGFR3, GSK3β, PDGFRβ, etc.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 9,000 | |||
2 mg | 在庫あり | ¥ 12,500 | |||
5 mg | 在庫あり | ¥ 18,500 | |||
10 mg | 在庫あり | ¥ 34,500 | |||
25 mg | 在庫あり | ¥ 61,000 | |||
50 mg | 在庫あり | ¥ 97,500 | |||
100 mg | 在庫あり | ¥ 144,500 | |||
500 mg | 在庫あり | ¥ 310,000 |
説明 | CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively. It is less potent to FGFR3, GSK3β, PDGFRβ, etc. |
ターゲット&IC50 | Aurora A:42 nM, Aurora B:198 nM, Aurora C:227 nM |
分子量 | 497.02 |
分子式 | C23H25ClN8OS |
CAS No. | 942947-93-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6 mM
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCT129202 942947-93-5 Cell Cycle/Checkpoint Chromatin/Epigenetic Aurora Kinase inhibit Inhibitor CCT 129202 CCT-129202 inhibitor